Literature DB >> 24796565

Antifibrinolytic mechanisms in acute airway injury after sulfur mustard analog inhalation.

Raymond C Rancourt1, Aftab Ahmad, Livia A Veress, Jacqueline S Rioux, Rhonda B Garlick, Carl W White.   

Abstract

Acute lung injury in response to mustard gas (sulfur mustard [SM]) inhalation results in formation of fibrin casts, which obstruct the airway. The objective of this study was to identify fibrinolytic pathways that could be contributing to the persistence of airway casts after SM exposure. Rats were exposed to the SM analog, 2-chloroethyl ethyl sulfide, via nose-only aerosol inhalation. At 4 and 18 hours after exposure, animals were killed and airway-capillary leak estimated by measuring bronchoalveolar lavage fluid (BALF) protein and IgM content. The fibrin clot-degrading and plasminogen-activating capabilities of BALF were also assessed by activity assays, whereas Western blotting was used to determine the presence and activities of plasminogen activator inhibitor-1, thrombin activatable fibrinolytic inhibitor and α2-antiplasmin. Measurement of tissue-specific steady-state mRNA levels was also conducted for each fibrinolytic inhibitor to assess whether its synthesis occurs in lung or at extrapulmonary sites. The results of this study demonstrate that fibrin-degrading and plasminogen-activating capabilities of the airways become impaired during the onset of 2-chloroethyl ethyl sulfide-induced vascular leak. Findings of functionally active reservoirs of plasminogen activator inhibitor-1, thrombin activatable fibrinolysis inhibitor, and α2-antiplasmin in BALF indicate that airway fibrinolysis is inhibited at multiple levels in response to SM.

Entities:  

Keywords:  lung injury; plasminogen activator inhibitor-1; sulfur mustard; thrombin activatable fibrinolysis inhibitor; α2-antiplasmin

Mesh:

Substances:

Year:  2014        PMID: 24796565      PMCID: PMC4189487          DOI: 10.1165/rcmb.2014-0012OC

Source DB:  PubMed          Journal:  Am J Respir Cell Mol Biol        ISSN: 1044-1549            Impact factor:   6.914


  21 in total

1.  Molecular mechanism of the cytotoxic action of difunctional alkylating agents and of resistance to this action.

Authors:  P D Lawley; P Brookes
Journal:  Nature       Date:  1965-05-01       Impact factor: 49.962

2.  Absence of thrombin-activatable fibrinolysis inhibitor protects against sepsis-induced liver injury in mice.

Authors:  Rosemarijn Renckens; Joris J T H Roelofs; Simone A J ter Horst; Cornelis van 't Veer; Stefan R Havik; Sandrine Florquin; Gerry T M Wagenaar; Joost C M Meijers; Tom van der Poll
Journal:  J Immunol       Date:  2005-11-15       Impact factor: 5.422

3.  Kinetics of the activation of plasminogen by human tissue plasminogen activator. Role of fibrin.

Authors:  M Hoylaerts; D C Rijken; H R Lijnen; D Collen
Journal:  J Biol Chem       Date:  1982-03-25       Impact factor: 5.157

4.  Plasma carboxypeptidases as regulators of the plasminogen system.

Authors:  A Redlitz; A K Tan; D L Eaton; E F Plow
Journal:  J Clin Invest       Date:  1995-11       Impact factor: 14.808

5.  Role of cell-surface lysines in plasminogen binding to cells: identification of alpha-enolase as a candidate plasminogen receptor.

Authors:  L A Miles; C M Dahlberg; J Plescia; J Felez; K Kato; E F Plow
Journal:  Biochemistry       Date:  1991-02-12       Impact factor: 3.162

6.  Serial abnormalities of fibrin turnover in evolving adult respiratory distress syndrome.

Authors:  S Idell; K B Koenig; D S Fair; T R Martin; J McLarty; R J Maunder
Journal:  Am J Physiol       Date:  1991-10

Review 7.  Mustard gas: imminent danger or eminent threat?

Authors:  Matthew J Geraci
Journal:  Ann Pharmacother       Date:  2008-01-22       Impact factor: 3.154

8.  Clinical and morphological findings on mustard gas [bis(2-chloroethyl)sulfide] poisoning.

Authors:  W Eisenmenger; G Drasch; M von Clarmann; E Kretschmer; G Roider
Journal:  J Forensic Sci       Date:  1991-11       Impact factor: 1.832

9.  Thrombin-activatable fibrinolysis inhibitor protects against acute lung injury by inhibiting the complement system.

Authors:  Masahiro Naito; Osamu Taguchi; Tetsu Kobayashi; Takehiro Takagi; Corina N D'Alessandro-Gabazza; Yuki Matsushima; Daniel Boveda-Ruiz; Paloma Gil-Bernabe; Takahiro Matsumoto; Ayshwarya-Lakshmi Chelakkot-Govindalayathil; Masaaki Toda; Atsushi Yasukawa; Osamu Hataji; John Morser; Yoshiyuki Takei; Esteban C Gabazza
Journal:  Am J Respir Cell Mol Biol       Date:  2013-10       Impact factor: 6.914

10.  The plasminogen system and cell surfaces: evidence for plasminogen and urokinase receptors on the same cell type.

Authors:  E F Plow; D E Freaney; J Plescia; L A Miles
Journal:  J Cell Biol       Date:  1986-12       Impact factor: 10.539

View more
  13 in total

1.  Bronchiolitis Obliterans and Pulmonary Fibrosis after Sulfur Mustard Inhalation in Rats.

Authors:  Matthew D McGraw; Marilyn M Dysart; Tara B Hendry-Hofer; Paul R Houin; Jaqueline S Rioux; Rhonda B Garlick; Joan E Loader; Russell Smith; Danielle C Paradiso; Wesley W Holmes; Dana R Anderson; Carl W White; Livia A Veress
Journal:  Am J Respir Cell Mol Biol       Date:  2018-06       Impact factor: 6.914

2.  From the Cover: ImpairedProliferation and Differentiation of the Conducting Airway Epithelium Associated With Bronchiolitis Obliterans After Sulfur Mustard Inhalation Injury in Rats.

Authors:  Matthew D McGraw; Jaqueline S Rioux; Rhonda B Garlick; Raymond C Rancourt; Carl W White; Livia A Veress
Journal:  Toxicol Sci       Date:  2017-06-01       Impact factor: 4.849

Review 3.  Fibrinolysis Shutdown in Trauma: Historical Review and Clinical Implications.

Authors:  Hunter B Moore; Ernest E Moore; Matthew D Neal; Forest R Sheppard; Lucy Z Kornblith; Dominik F Draxler; Mark Walsh; Robert L Medcalf; Mitch J Cohen; Bryan A Cotton; Scott G Thomas; Christine M Leeper; Barbara A Gaines; Angela Sauaia
Journal:  Anesth Analg       Date:  2019-09       Impact factor: 5.108

Review 4.  Antioxidants as potential medical countermeasures for chemical warfare agents and toxic industrial chemicals.

Authors:  Cameron S McElroy; Brian J Day
Journal:  Biochem Pharmacol       Date:  2015-10-22       Impact factor: 5.858

5.  Methyl isocyanate inhalation induces tissue factor-dependent activation of coagulation in rats.

Authors:  Raymond C Rancourt; Jacqueline S Rioux; Livia A Veress; Rhonda B Garlick; Claire R Croutch; Eric Peters; William Sosna; Carl W White
Journal:  Drug Chem Toxicol       Date:  2018-11-14       Impact factor: 3.356

6.  Acute cytotoxicity and increased vascular endothelial growth factor after in vitro nitrogen mustard vapor exposure.

Authors:  Matthew D McGraw; So-Young Kim; Carl W White; Livia A Veress
Journal:  Ann N Y Acad Sci       Date:  2020-05-14       Impact factor: 5.691

7.  An Official American Thoracic Society Workshop Report: Chemical Inhalational Disasters. Biology of Lung Injury, Development of Novel Therapeutics, and Medical Preparedness.

Authors:  Eleanor M Summerhill; Gary W Hoyle; Sven-Eric Jordt; Bronwen J Jugg; James G Martin; Sadis Matalon; Steven E Patterson; David J Prezant; Alfred M Sciuto; Erik R Svendsen; Carl W White; Livia A Veress
Journal:  Ann Am Thorac Soc       Date:  2017-06

Review 8.  Emerging targets for treating sulfur mustard-induced injuries.

Authors:  Shama Ahmad; Aftab Ahmad
Journal:  Ann N Y Acad Sci       Date:  2016-06-10       Impact factor: 5.691

9.  Editor's Highlight: Pulmonary Vascular Thrombosis in Rats Exposed to Inhaled Sulfur Mustard.

Authors:  Matthew D McGraw; Christopher M Osborne; Emily J Mastej; Jorge A Di Paola; Dana R Anderson; Wesley W Holmes; Danielle C Paradiso; Rhonda B Garlick; Tara B Hendry-Hofer; Raymond C Rancourt; Russell W Smith; Carol Burns; Gates B Roe; Jacqueline S Rioux; Carl W White; Livia A Veress
Journal:  Toxicol Sci       Date:  2017-10-01       Impact factor: 4.849

Review 10.  Mustard vesicant-induced lung injury: Advances in therapy.

Authors:  Barry Weinberger; Rama Malaviya; Vasanthi R Sunil; Alessandro Venosa; Diane E Heck; Jeffrey D Laskin; Debra L Laskin
Journal:  Toxicol Appl Pharmacol       Date:  2016-05-19       Impact factor: 4.219

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.